Exact Sciences
EXAS
#1729
Rank
NZ$17.14 B
Marketcap
$92.66
Share price
2.58%
Change (1 day)
-11.59%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

Earnings for Exact Sciences (EXAS)

Earnings in 2024 (TTM): -NZ$0.32 Billion

According to Exact Sciences's latest financial reports the company's current earnings are NZ$2.69 Billion. In 2023 the company made an earning of -NZ$0.34 Billion, an increase over its 2022 earnings that were of -NZ$1.11 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Exact Sciences from 2001 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -NZ$0.32 Billion-7.79%
2023 -NZ$0.34 Billion-69.28%
2022 -NZ$1.11 Billion-25.55%
2021 -NZ$1.49 Billion1.68%
2020 -NZ$1.47 Billion271.17%
2019 -NZ$0.4 Billion58.99%
2018 -NZ$0.25 Billion20.89%
2017 -NZ$0.21 Billion-30.95%
2016 -NZ$0.3 Billion5.09%
2015 -NZ$0.29 Billion57.24%
2014 -NZ$0.18 Billion116.53%
2013 -NZ$82.91 Million
2011 -NZ$51.62 Million143.73%
2010 -NZ$21.18 Million27.85%
2009 -NZ$16.57 Million0.27%
2008 -NZ$16.53 Million-20.95%
2007 -NZ$20.9 Million-13.53%
2006 -NZ$24.17 Million-10.07%
2005 -NZ$26.88 Million-21.81%
2004 -NZ$34.38 Million-33.44%
2003 -NZ$51.65 Million-6.51%
2002 -NZ$55.24 Million17.95%
2001 -NZ$46.84 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-NZ$0.21 Billion-40.71%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.11 B-134.38%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$14.63 Million-95.74%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$62.62 Million-81.75%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$13.26 B-3,966.20%๐Ÿ‡ซ๐Ÿ‡ท France